Sevoflurane promotes the apoptosis of laryngeal squamous cell carcinoma in-vitro and inhibits its malignant progression via miR-26a/FOXO1 axis

Laryngeal squamous cell carcinoma (LSCC) is a laryngeal malignancy with a high mortality rates, and its treatment remains difficult. Sevoflurane is a surgical anesthesia which has anti-tumor effect. This investigation assessed the effects of LSCC cells treatment with Sevoflurane in vitro and in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dan, Wan, Lang, Gong, Hao, Chen, Shiming, Kong, Yonggang, Xiao, Bokui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806578/
https://www.ncbi.nlm.nih.gov/pubmed/34511023
http://dx.doi.org/10.1080/21655979.2021.1962684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806578/
https://www.ncbi.nlm.nih.gov/pubmed/34511023
http://dx.doi.org/10.1080/21655979.2021.1962684

Ejemplares similares